The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples